Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo

Biochemical Pharmacology

Volumn 51, Issue 5, 1996, Pages 693-700

  Atamna, Hani ^a   Krugliak, Miriam ^a   Shalmiev, Gavriel ^a   Deharo, Eric ^b   Pescarmona, Gianpiero ^c   Ginsburg, Hagai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

antimalarial action; hexose monophosphate shunt; methylene blue; murine malarias; phenothiazines; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; AZINE; AZURE A; AZURE B; AZURE C; CELESTIN BLUE; HEME; METHYLENE BLUE; METHYLENE BLUE DERIVATIVE; OXAZINE; PHENOSAFRANIN; THIONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CELL GROWTH; CELL LINE; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; HEXOSE MONOPHOSPHATE SHUNT; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PLASMODIUM; PLASMODIUM FALCIPARUM; PLASMODIUM VINCKEI; PLASMODIUM YOELII; PRIORITY JOURNAL;

EID: 0029987752     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(95)02258-9     Document Type: Article

References (46)

1. Guttman P and Ehrlich P, Über die Wirkung de Methylenblau bei Malaria. Berl Klin Wochenschr 28: 953-956, 1891.
2. Peters W, Chemotherapy and Drug Resistance in Malaria. London, Academic Press, 1970.
3. Thurston JP, The chemotherapy of Plasmodium berghei. I. Resistance to drugs. Parasitology 43: 246-252, 1953.
4. Dorvault F, L'Officine. Paris, Editions Vigot, 1984.
5. Steck EA, Pamaquine. In: The Chemotherapy of Protozoan Disease, Vol. III, sect. 4-5, Washington, D.C., Division of Medicinal Chemistry, Walter Reed Army Institute of Research, pp. 146-162, 1972.
6. Carson PE, 8-amioquinolines. In: Handbook of Experimental Pharmacology 68/II. Antimalarial Drugs (Eds. Peters W and Richards WHO), pp. 83-122. Berlin, Springer-Verlag, 1984.
7. Mansouri A, Review: Methemoglobinemia. Am J Med Sci 289: 200-209, 1985.
8. Layne WR and Smith RP, Methylene blue uptake and the reversal of chemically induced methemoglobinemias in human erythrocytes. J Pharmacol Exp Ther 165: 36-44, 1969.
9. Atamna H, Pascarmona G and Ginsburg H, Hexose-monophosphate shunt activity in intact Plasmodium falciparum infected erythrocytes and in free parasites. Mol Biochem Parasitol 67: 79-89, 1994.
10. Stryer L, Biochemistry. New York, W.H. Freeman, 1988.
11. Ginsburg H, Krugliak M, Eidelman O and Cabantchik ZI, New permeability pathways induced in membranes of Plasmodium falciparum infected erythrocytes. Mol Biochem Parasitol 8: 177-190, 1983.
12. Shalmiev G and Ginsburg H, The susceptibility of the malarial parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes. Biochem Pharmacol 46: 365-374, 1993.
13. Osgood EE and Brooke JH, Continuous tissue culture of leukocytes from human leukemic blood by application of "gradient" principle. Blood 51: 1010-1022, 1955.
14. Jensen JB, Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum. Am J Trop Med Hyg 27: 1274-1276, 1978.
15. Ager AL Jr, Rodent malaria models. In: Handbook of Experimental Therapeutics 68/I. Antimalarial Drugs (Eds. Peters W and Richards WHG), pp 225-264. Berlin, Springer-Verlag, 1984.
16. Blauer G and Ginsburg H, Complexes of antimalarial drugs with ferriprotoporphyrin IX. Biochem Internatl 5: 519-523, 1982.
17. Vennerstrom JL, Makler MT, Angerhofer CK and Williams JA, Antimalarial dyes revisited: Xanthenes, azines, oxazines, and thiazines. Antimicrob Agents Chemother, in press.
18. Beauté-Lafitte A, Altemayer-Caillard V, Gonnet-Gonzalez F, Ramiaramanana L, Chabaud AG and Landau I, The chemosensitivity of the rodent malarias - Relationships with the biology of merozoites. Int J Parasitol 24: 981-986, 1994.
19. Cambie G, Caillard V, Beauté-Lafitte A, Ginsburg H, Chabaud A and Landau I, Chronotherapy of malaria: Identification of drug sensitive stage of parasite and timing of drug delivery for improved therapy. Ann Parasit Hum Comp 66: 14-21, 1991.
20. Cambie G, Verdier F, Gaudebout C, Clavier F and Ginsburg H, The pharmacokinetics of chloroquine in healthy and Plasmodium chobaudi-infected mice: Implications for chronotherapy. Parasite 1: 219-226, 1994.
21. Beauté-Lafitte A, Altemayer-Caillard V, Chabaud A and Landau I, Plasmodium yoelii nigeriensis: Biological mechanisms of resistance to chloroquine. Parasite 1: 227-233, 1994-
22. Wopschall RH and Shain I, Adsorption characteristics of the methylene blue system using stationary electrode polarography. Anal Chem 39: 1527-1534, 1967.
23. Tuite EM and Norden B, Sequence-specific interactions of methylene blue with polynucleotides and DNA: A spectroscopic study. J Am Chem Soc 116: 7548-7556, 1994.
24. Keene JP, Land EJ and Swallow AJ, A pulse radiolysis study of methylene blue. In: Pulse Radiolysis (Eds. Ebert M, Keene JP, Swallow AJ and Baxendale JH), pp. 227-244. London, Academic Press, 1965.
25. Pottier R, Bonneau R and Joussot-Dubien J, pH-dependence of singlet oxygen production in aqueous solutions using toluidine blue as a photosensitizer. Photochem Photobiol 22: 59-61, 1975.
26. Tuite EM and Kelly JM, Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B:Biol 21: 103-124, 1993.
27. Sass MD, Caruso CJ and Axelrod DR, Accumulation of methylene blue by metabolizing erythrocytes. J Lab Clin Med 69: 447-455, 1967.
28. Sass MD, Caruso CJ and Axelrod DR, Mechanism of TPNH-linked reduction of methemoglobin by methylene blue. Clin Chim Acta 24: 77-85, 1969.
29. Bonneau R, Faure J and Joussot-Dubien J, Purification des colorants thiaziniques, azur A, azur B, azur C, par une methode de partage. Talanta 14: 121-122, 1967.
30. Bergmann K and O'Konski CT, A spectroscopic study of methylene blue monomer, dimer, and complexes with montmorillonite. J Phys Chem 67: 2169-2177, 1963.
31. Roos A and Boron W, Intracellular pH. Physiol Rev 61: 296-434, 1981.
32. Blauer G, Optical activity of ferriheme-quinine complexes. Biochem Internatl 6: 777-782, 1983.
33. Blauer G, Optical properties of ferriheme-quinidine complexes. In: Optical Properties and Structure of Tetrapyrroles (Eds. Blauer G and Sund H), pp. 137-152. Walter de Gruyter, Berlin, 1985.
34. Blauer G, Optical properties of complexes of antimalarial drugs with ferriprotoporphyrin IX an aqueous medium. II The system ferriprotoporphyrin IX-quinidine. Arch Biochem Biophys 251: 315-322, 1986.
35. Blauer G, Optical properties of complexes of antimalarial drugs with ferriprotoporphyrin IX an aqueous medium. I The system ferriprotoporphyrin IX-quinine. Arch Biochem Biophys 251: 306-314, 1986.
36. Bauminger E, May L and Blauer G, Mössbauer studies of ferriheme-quinidine complexes. Inorg Chim Acta 151: 277-280, 1988.
37. Blauer G, Interaction of ferriprotoporphyrin IX with the antimalarials amodiaquine and halofantrine. Biochem Int 17: 729-734, 1988.
38. Blauer G, Akkawi M and Bauminger ER, Further evidence for the interaction of the antimalarial drug amodiaquine with ferriprotoporphyrin-IX. Biochem Pharmocol 46: 1573-1576, 1993.
39. Ginsburg H and Krugliak M, Quinoline-containing anti-malarials - mode of action, drug resistance and its reversal - an update with unresolved puzzles. Biochem Pharmacol 43: 63-70, 1992.
40. Slater AF, Chloroquine - mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther 57: 203-235, 1993.
41. Slater AF and Cerami A, Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169, 1992.
42. Egan TJ, Ross DC and Adams PA, Quinoline anti-malarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett 352: 54-57, 1994.
43. Dorn A, Stoffel R, Matile H, Bubendorf A and Ridley RG, Malarial haemozoin beta-haematin supports haem polymerization in the absence of protein. Nature 374: 269-271, 1995.
44. Ladda RL, Morphologic observations on the effect of antimalarial agents on the erythrocytic forms of Plasmodium berghei in vitro. Milit Med 131 (Suppl.): 993-1008, 1966.
45. Peters W, I. Malaria. Rational methods in the search for antimalarial drugs. Trans R Soc Trop Med Hyg 61: 400-411, 1967.
46. Ellenhorn MJ and Barceloux DG, Medical Toxicology. Diagnosis and Treatment of Human Poisoning. New York, Elseiver, 1988.